Dong-A Socio Holdings Co.,Ltd
Financials
Valuation Metrics
Dong-A Socio Holdings Co.,Ltd's Market Cap is ₩5925B. At end of 2025 it was ₩7166B. Ranked #388 of 2,436 in KR market (top 16%), #265 of 787 on KOSPI (top 34%), #43 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 18%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 592.46B KRW | KR#388/2,436 Sec#43/234 |
| Revenue | 1.45T KRW | KR#315/2,436 Sec#11/234 |
| Net Income | 94.00B KRW | KR#228/2,436 Sec#13/234 |
| Total Assets | 2.12T KRW | KR#290/2,436 Sec#11/234 |
| Net Assets | 1.18T KRW | KR#248/2,436 Sec#12/234 |
| Employees | 82 | KR#1,777/2,436 Sec#145/234 |
| Value | ||
| P/E | 6.30x | KR#432/2,436 Sec#18/234 |
| P/B | 0.50x | KR#846/2,436 Sec#38/234 |
| PEG | 0.45x | KR#652/2,436 Sec#38/234 |
| P/S | 0.41x | KR#811/2,436 Sec#26/234 |
| EV/EBITDA | 10.59x | KR#648/2,436 Sec#30/234 |
| FCF Yield | 30.07% | KR#205/2,436 Sec#3/234 |
| Profitability | ||
| ROE | 7.96% | KR#698/2,436 Sec#44/234 |
| ROA | 4.44% | KR#718/2,436 Sec#59/234 |
| Op. Margin | 6.65% | KR#737/2,436 Sec#62/234 |
| Revenue Growth | 6.88% | KR#1,077/2,436 Sec#99/234 |
| Earnings Growth | 14.11% | KR#802/2,436 Sec#52/234 |
| Financial Health | ||
| Debt Ratio | 79.26% | KR#266/2,436 Sec#35/234 |
| Total Debt | 560.68B KRW | KR#278/2,436 Sec#9/234 |
| FCF | 178.13B KRW | KR#123/2,436 Sec#3/234 |
| Cash | 130.91B KRW | KR#385/2,436 Sec#17/234 |
| Current Ratio | 0.79x | KR#2,049/2,436 Sec#197/234 |
| Net Debt/EBITDA | 4.45x | KR#1,055/2,436 Sec#82/234 |
| Dividend | ||
| Div. Yield | 1.92% | KR#936/2,436 Sec#48/234 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/234 |
| Performance | ||
| 1Y Return | -17.70% | KR#1,078/2,436 Sec#78/234 |
| 1M Return | 6.28% | KR#220/2,436 Sec#14/234 |
| From 52W High | -27.80% | KR#308/2,436 Sec#19/234 |
| 1Y MDD | -37.06% | KR#408/2,436 Sec#30/234 |
| Trading | ||
| Volume | 16,623 shares | KR#2,100/2,436 Sec#207/234 |
| Foreign Own. | 16.33% | KR#287/2,436 Sec#15/234 |
| Per Share | ||
| EPS | 13,918 KRW | KR#52/2,436 Sec#5/234 |
| BPS | 173,176 KRW | KR#70/2,436 Sec#2/234 |
Company Info
Dong-A Socio Holdings, established in 1949 and listed on the KOSPI in 1970, transitioned to a holding company structure in 2014. It operates seven reporting divisions including manufacturing and sales of OTC drugs and quasi-drugs, biosimilar and CMO production, logistics, and manufacturing of packaging containers and bottled water, with subsidiaries Dong-A ST and ST Pharm. This holding company structure supports independent decision-making and autonomous management for its subsidiaries, strengthening business competitiveness and securing growth potential. Dong-A Socio Holdings is headquartered in Dongdaemun-gu, Seoul.